Pfizer Inc. and BioNTech SE have agreed to a letter of intent regarding the co-development and distribution (excluding C...
International Women’s Day 2020 embracing the world with its new campaign #EachForEqual, aiming...
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for...
AbCellera and Eli Lilly and Company have announced that they have entered into an agreement to co-develop antibody (Ab) ...
Singapore , 12 March 2020 Here's the full address: My fellow Singaporeans, good...
UN Humanitarian Chief Mark Lowcock has released US$15 million from the Central Emergency Response Fund (CERF) to help fu...
Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune di...
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard have committed up to $125 million in seed funding to s...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
Berkeley Lights, a leader in cell selection, on 6 March 2020 launched their new T Cell Receptor Sequencing Kit (TCRseq K...
US based LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, is making it...
A new paper authored by statistical experts at Cytel has been published in the world-renowned journal CA: A Cancer Journ...
After careful consideration, the U.S. Food and Drug Administration (FDA) has published a final rule to ban electrical st...
Coronavirus detection assay depends on its genetic sequences identification. But as the number of potential cases increa...
Sona Nanotech Inc. and GE Healthcare Life Sciences will jointly complete test development of the Sona Covid-19 Coronavir...
BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, on 2 March 2020 annou...
US based Seva Foundation has announced a call for ideas to identify innovative technology-based solutions to improve eye...
Gilead Sciences, has announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of rem...